Skip to main content

Table 2 Patient characteristics and anal function results

From: A novel evaluation technique for measuring the distance between the anastomosis and intersphincteric groove via three-dimensional endoanal ultrasonography in children with Hirschsprung disease

 

Soiling

Constipation

No soiling

Grade 1

Grade 3

No constipation

Grade 3

n = 4

n = 4

n = 3

n = 4

n = 7

Age at evaluation (years)

8 [8–14]

6 [3–7]

6 [4–10]

8 [8–14]

6 [3–10]

Male (%)

4 (100)

4 (100)

3 (100)

4 (100)

7 (100)

Gestational age

36w6d [33w2d–40w0d]

39w1d [38w6d–40w0d]

40w3d [38w4d–41w0d]

36w6d [33w2d–40w0d]

39w3d [38w4d–41w0d]

Birth weight (g)

2743 [1763–3310]

3036 [2756–3236]

3152 [3140–3336]

2743 [1763–3310]

3152 [2756–3336]

Comorbidity (%)

 None

4 (100)

3 (75.0)

1 (33.3)

4 (100)

4 (57.1)

 Jejunoileal atresia

0 (0.0)

0 (0.0)

1 (33.3)

0 (0.0)

1 (14.3)

 Intestinal malrotation

0 (0.0)

1 (25.0)

0 (0.0)

0 (0.0)

1 (14.3)

 Waardenburg syndrome and developmental delay

0 (0.0)

0 (0.0)

1 (33.3)

0 (0.0)

1 (14.3)

Age at operation (months)

2 [1–5]

3 [0–59]

4 [4–5]

2 [1–5]

4 [0–59]

Colostomy (%)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

The part of the colon anastomosed with the anus (%)

Sigmoid

3 (75.0)

2 (50.0)

2 (66.7)

3 (75.0)

4 (57.1)

Descending

1 (25.0)

2 (50.0)

1 (33.3)

1 (25.0)

3 (42.9)

Bowel management at examination

 None (%)

4 (100)

0 (0.0)

0 (0.0)

4 (100)

0 (0.0)

 Osmotic laxatives (%)a

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Stimulant laxatives (%)b

0 (0.0)

1 (25.0)

0 (0.0)

0 (0.0)

1 (14.3)

 Probiotics

0 (0.0)

2 (50.0)

1 (33.3)

0 (0.0)

3 (42.9)

 Glycerin enema (%)

0 (0.0)

4 (100)

3 (100)

0 (0.0)

7 (100)

 Other stool softenersc

0 (0.0)

1 (25.0)

0 (0.0)

0 (0.0)

1 (14.3)

 Transanal irrigation (%)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Loperamide

0 (0.0)

1 (25.0)

1 (33.3)

0 (0.0)

2 (28.6)

Postoperative complications

 Wound dehiscence (%)

0 (0.0)

0 (0.0)

1 (33.3)

0 (0.0)

1 (14.3)

 Anastomotic stricture (%)

0 (0.0)

1 (25.0) †

0 (0.0)

0 (0.0)

1 (14.3)d

  1. Values are presented as median [range] or number (%)
  2. AP anterior-posterior position
  3. aMagnesium oxide
  4. bSodium picosulfate and sennosides
  5. Malt extract
  6. cThis patient required strictureplasty later